359 related articles for article (PubMed ID: 32504765)
1. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
[TBL] [Abstract][Full Text] [Related]
2. Effective inhibition of Cbf-14 against Cryptococcus neoformans infection in mice and its related anti-inflammatory activity.
Yu C; Wei S; Han X; Liu H; Wang M; Jiang M; Guo M; Dou J; Zhou C; Ma L
Fungal Genet Biol; 2018 Jan; 110():38-47. PubMed ID: 29221882
[TBL] [Abstract][Full Text] [Related]
3. Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis.
Wiederhold NP; Najvar LK; Bocanegra R; Kirkpatrick WR; Sorrell TC; Patterson TF
Antimicrob Agents Chemother; 2013 Feb; 57(2):745-50. PubMed ID: 23165465
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
Lu R; Hollingsworth C; Qiu J; Wang A; Hughes E; Xin X; Konrath KM; Elsegeiny W; Park YD; Atakulu L; Craft JC; Tramont EC; Mannino R; Williamson PR
mBio; 2019 May; 10(3):. PubMed ID: 31138748
[No Abstract] [Full Text] [Related]
5. A synthetic peptide as a novel anticryptococcal agent.
Cenci E; Bistoni F; Mencacci A; Perito S; Magliani W; Conti S; Polonelli L; Vecchiarelli A
Cell Microbiol; 2004 Oct; 6(10):953-61. PubMed ID: 15339270
[TBL] [Abstract][Full Text] [Related]
6. New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans
Lu RY; Ni TJ; Wu J; Yan L; Lv QZ; Li LP; Zhang DZ; Jiang YY
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791946
[TBL] [Abstract][Full Text] [Related]
7. A Peptide from Budding Yeast GAPDH Serves as a Promising Antifungal against Cryptococcus neoformans.
Zhang Y; Zhou L; Liu Y; Zhao X; Lian X; Zhang J; Zhao D; Wang Y; Zhong J; Wang J; Wang H; Wang L; Fu YV
Microbiol Spectr; 2022 Feb; 10(1):e0082621. PubMed ID: 35019693
[TBL] [Abstract][Full Text] [Related]
8. The Antimicrobial Peptide MK58911-NH
Singulani JL; Oliveira LT; Ramos MD; Fregonezi NF; Gomes PC; Galeane MC; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0090421. PubMed ID: 34516241
[TBL] [Abstract][Full Text] [Related]
9. Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice.
Du W; Li H; Tian B; Sai S; Gao Y; Lan T; Meng Y; Ding C
Colloids Surf B Biointerfaces; 2019 Nov; 183():110446. PubMed ID: 31465938
[TBL] [Abstract][Full Text] [Related]
10. CD4
Neal LM; Xing E; Xu J; Kolbe JL; Osterholzer JJ; Segal BM; Williamson PR; Olszewski MA
mBio; 2017 Nov; 8(6):. PubMed ID: 29162707
[No Abstract] [Full Text] [Related]
11. Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease.
Nixon GL; McEntee L; Johnson A; Farrington N; Whalley S; Livermore J; Natal C; Washbourn G; Bibby J; Berry N; Lestner J; Truong M; Owen A; Lalloo D; Charles I; Hope W
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29311092
[TBL] [Abstract][Full Text] [Related]
12. An active domain SA-2 derived from cystatin-SA, and its antifungal activity.
Liu X; Huang X; Wang J; Zhang M; Liu M; Zhou C; Ma L
Amino Acids; 2023 Jan; 55(1):101-112. PubMed ID: 36333524
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antifungal activity of cinnamaldehyde against Cryptococcus neoformans var. grubii.
Neelabh ; Singh K
Folia Microbiol (Praha); 2020 Dec; 65(6):973-987. PubMed ID: 32617865
[TBL] [Abstract][Full Text] [Related]
14. Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro.
Feldmesser M; Mukherjee J; Casadevall A
J Antimicrob Chemother; 1996 Mar; 37(3):617-22. PubMed ID: 9182119
[TBL] [Abstract][Full Text] [Related]
15. Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays.
Treviño-Rangel Rde J; Villanueva-Lozano H; Hernández-Rodríguez P; Martínez-Reséndez MF; García-Juárez J; Rodríguez-Rocha H; González GM
Med Mycol; 2016 Mar; 54(3):280-6. PubMed ID: 26705833
[TBL] [Abstract][Full Text] [Related]
16. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts.
Benincasa M; Scocchi M; Pacor S; Tossi A; Nobili D; Basaglia G; Busetti M; Gennaro R
J Antimicrob Chemother; 2006 Nov; 58(5):950-9. PubMed ID: 17023499
[TBL] [Abstract][Full Text] [Related]
17. Development of Antifungal Peptides against Cryptococcus neoformans; Leveraging Knowledge about the
Tancer RJ; Wang Y; Pawar S; Xue C; Wiedman GR
Microbiol Spectr; 2022 Apr; 10(2):e0043922. PubMed ID: 35377230
[TBL] [Abstract][Full Text] [Related]
18. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
[TBL] [Abstract][Full Text] [Related]
19. Novel antimicrobial peptide DvAMP serves as a promising antifungal agent against Cryptococcus neoformans.
Yang L; Tian Z; Zhao W; Zhang J; Tian C; Zhou L; Jiao Z; Peng J; Guo G
Bioorg Chem; 2023 Sep; 138():106679. PubMed ID: 37329812
[TBL] [Abstract][Full Text] [Related]
20. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
Spadari CC; Vila T; Rozental S; Ishida K
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
